SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: StockMiser who wrote (19331)3/8/1999 3:30:00 PM
From: Mark A. Stang  Read Replies (1) | Respond to of 23519
 
NO SALE

I don't care if VVUS goes up to 8 or back to 2 1/2 by the end of the week-- staying long, won't sell one of my 25K shares. These are big moves in percentage terms only because we're moving off a ridiculously undervalued base.




To: StockMiser who wrote (19331)3/8/1999 3:30:00 PM
From: Forest Gump  Respond to of 23519
 
Nina Ferrari
Christina Cheddar

maybe they have a Chuck Roast working for them also



To: StockMiser who wrote (19331)3/8/1999 4:42:00 PM
From: blankmind  Read Replies (1) | Respond to of 23519
 
Did you see this on the post:

"The spokeswoman said Vivus expects to receive marketing clearance for
Muse in Spain, Italy and France in the first half. With each clearance, it will receive a $2 million milestone
payment from Astra AB (A), its European marketing partner."


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News